Xiangbei Welman Pharmaceuticals is a leading innovative high-tech pharmaceutical group in China specializing in research, development, production, and sales of anti-drug-resistant and anti-infective drugs. One of their domestic production centers has developed into one of China’s top five antibiotic production bases. The antibiotic industry employs many people, with complex clinical environments and strict regulations. This presents exceptionally high demands for the efficiency, accuracy, stability, and traceability of pharmacovigilance activities, especially signal detection.
It is crucial to set reasonable detection strategies for risk signals, such as medical and quality signals, which require consideration of different detection standards. The eSafety solution offers various signal detection solutions, including traditional detection methods, computer-assisted detection methods, and cluster analysis.
Reading Time: 3 minutes GreenLight Clinical, a physician-led solutions-focused Clinical CRO, and Taimei Technology have joined forces to accelerate clinical research. This partnership leverages Taimei’s AI-driven
Reading Time: 4 minutes Together, Taimei Technology and Evrima Technologies, shed light on the challenges surrounding patient recruitment and approaches that positively impact patient recruitment and
Reading Time: 2 minutes By leveraging innovative technologies such as EDC and eCOA platforms, researchers and sponsors can enhance trial efficiency, data quality, and regulatory compliance,
Keep up with our latest news
Keep up with our latest news
